Shoji Fukumoto Selected Research

(7- (5- fluoro- 2- methylphenyl)- 4- methyl- 7,8- dihydro- 5(6H)- quinolinylideneamino)guanidine

4/2002

In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shoji Fukumoto Research Topics

Disease

2	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 01/2018
2	Heart Failure 01/2017 - 12/2011
1	Cognitive Dysfunction 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2011
1	Hypertension (High Blood Pressure) 12/2011
1	Contracture 04/2002
1	Infarction (Infarctions) 04/2002
1	Myocardial Infarction 04/2002
1	Reperfusion Injury 04/2002

Drug/Important Bio-Agent (IBA)

1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2019
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2018
1	1,2,3,4-tetrahydroisoquinolineIBA 01/2018
1	Type 2 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017
1	G-Protein-Coupled Receptor Kinase 2IBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 12/2011
1	cariporideIBA 04/2002
1	eniporideIBA 04/2002
1	(7- (5- fluoro- 2- methylphenyl)- 4- methyl- 7,8- dihydro- 5(6H)- quinolinylideneamino)guanidineIBA 04/2002
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2002
1	Guanidine (Guanidine Nitrate)FDA Link 04/2002

Therapy/Procedure

1	Intravenous Administration 04/2002